Hepatic Cysts

Hepatic cysts are fluid-filled cavities within the liver parenchyma, which may be congenital or acquired. They can be solitary or multiple, ranging from microscopic to massive, and may be asymptomatic or cause clinical signs due to mass effect, rupture, or infection. In veterinary medicine, hepatic cysts are classified into several types: simple (bile duct) cysts, polycystic liver disease (often associated with polycystic kidney disease), acquired cysts (e.g., post-traumatic, inflammatory, or neoplastic), and parasitic cysts (e.g., hydatid cysts caused by Echinococcus species). The clinical significance varies widely; many cysts are incidental findings, but large or multiple cysts can lead to hepatomegaly, abdominal distension, biliary obstruction, or portal hypertension. This entry provides a comprehensive overview of hepatic cysts in dogs and cats, covering etiology, pathophysiology, diagnosis, and management.

The etiology of hepatic cysts is diverse. Congenital cysts arise from developmental abnormalities of the biliary tree, such as failure of involution of embryonic bile ducts, leading to the formation of bile duct hamartomas or polycystic disease. Polycystic liver disease is often inherited as an autosomal dominant trait in certain breeds, particularly Persian cats and Cairn Terriers, and is frequently associated with polycystic kidney disease (PKD). Acquired cysts may result from trauma, inflammation (e.g., cholangitis), or biliary obstruction causing cystic dilation of bile ducts. Parasitic cysts, though rare in North America, are caused by Echinococcus granulosus (hydatid cysts) and can occur in dogs as intermediate or definitive hosts. Neoplastic cysts can arise from cystadenomas or cystadenocarcinomas of the biliary epithelium. Additionally, hepatic cysts may be part of a systemic cystic disease, such as in von Hippel-Lindau syndrome (rare in animals). The exact molecular triggers are not fully understood, but genetic mutations affecting ciliary function (e.g., PKD1, PKD2 genes) are implicated in polycystic disease.

Hepatic cysts are relatively uncommon in dogs and cats, but the exact prevalence is unknown due to frequent asymptomatic presentation. Congenital polycystic liver disease is most commonly reported in Persian cats, with a high prevalence of concurrent polycystic kidney disease (approximately 38% in some studies). In dogs, Cairn Terriers, West Highland White Terriers, and other terrier breeds may be predisposed to polycystic liver disease. Acquired cysts are more common in older animals, with no strong sex predilection. Parasitic cysts are regionally distributed, with higher incidence in areas where Echinococcus is endemic (e.g., Mediterranean, South America, parts of Asia). No significant seasonal variation is noted. The condition is often diagnosed incidentally during abdominal imaging for unrelated reasons, suggesting that many cases remain subclinical.

The pathophysiology of hepatic cysts depends on the underlying cause. Congenital cysts result from abnormal development of the biliary tree, where segments of bile ducts dilate and become isolated from the main ductal system, forming fluid-filled cavities. These cysts are lined by cuboidal or columnar epithelium and contain serous fluid. In polycystic disease, mutations in genes such as PKD1 or PKD2 lead to abnormal ciliary function in cholangiocytes, causing uncontrolled proliferation and fluid secretion, resulting in multiple cysts. Acquired cysts may arise from chronic inflammation or obstruction of bile ducts, leading to ductal dilation and cyst formation. Parasitic cysts (hydatid) are caused by larval stages of Echinococcus, which form slowly growing cystic lesions containing protoscolices. Large cysts can cause mechanical compression of adjacent hepatic parenchyma, leading to atrophy, fibrosis, and impaired liver function. If cysts become infected, they can cause abscessation and sepsis. Rupture of cysts can lead to peritonitis or anaphylactic shock (in parasitic cases). Portal hypertension may develop if cysts compress the portal vasculature, leading to ascites and acquired portosystemic shunts.

Predisposing factors for hepatic cysts include genetic predisposition, particularly in Persian cats and certain terrier breeds for polycystic disease. Age is a factor, as acquired cysts are more common in older animals. Concurrent conditions such as chronic hepatitis, cholangitis, or biliary obstruction may predispose to cyst formation. Trauma to the liver can lead to cystic degeneration. Immunosuppression may increase the risk of infectious cysts (e.g., bacterial abscesses that become cystic). Dietary factors are not directly implicated, but obesity may increase the risk of hepatic lipidosis, which can complicate cyst management. Medications that are hepatotoxic may exacerbate underlying liver disease and promote cyst formation. Environmental factors, such as exposure to Echinococcus eggs, are relevant in endemic areas.

Clinical signs of hepatic cysts are highly variable. Many animals are asymptomatic, and cysts are discovered incidentally. When signs occur, they are often due to massive hepatomegaly, compression of adjacent organs, or complications such as infection or rupture. Common signs include abdominal distension, lethargy, anorexia, vomiting, diarrhea, and weight loss. In cases of biliary obstruction, jaundice may be present. If portal hypertension develops, ascites and peripheral edema may occur. Pain may be evident on abdominal palpation. In acute complications like cyst rupture or infection, signs of peritonitis (fever, acute abdomen) or sepsis may be seen. In polycystic disease, concurrent renal cysts may lead to signs of chronic kidney disease (polyuria, polydipsia, azotemia). Neurological signs may occur if hepatic encephalopathy develops secondary to portosystemic shunting.

Differential diagnoses for hepatic cysts include: 1) Hepatic abscess – distinguished by fever, leukocytosis, and ultrasonographic findings of thick-walled, echogenic fluid with gas; culture of fluid yields bacteria. 2) Primary or metastatic hepatic neoplasia (e.g., hepatocellular carcinoma, biliary cystadenocarcinoma) – may appear as complex cystic masses on imaging; cytology/histopathology is definitive. 3) Biliary mucocele – characterized by inspissated bile, often with a stellate pattern on ultrasound; more common in dogs, associated with hyperadrenocorticism or hypothyroidism. 4) Hepatic hematoma – history of trauma, acute onset, and imaging shows echogenic or mixed echogenicity mass; may resolve over time. 5) Granulomatous disease (e.g., fungal or mycobacterial) – may have cystic appearance; histopathology and special stains are diagnostic. 6) Choledochal cyst – a congenital dilation of the common bile duct, often causing extrahepatic biliary obstruction; imaging shows a cystic structure near the porta hepatis. 7) Polycystic kidney disease – if hepatic cysts are present, renal cysts should be ruled out; ultrasonography of kidneys is essential. 8) Peritoneal pseudocyst – a fluid-filled structure adjacent to the liver, but not within the parenchyma; imaging and cytology differentiate. 9) Hydatid cyst (Echinococcus) – rare, but should be considered in endemic areas; serology and histopathology are confirmatory. 10) Liver lobe torsion – may present as a cystic mass with acute pain; imaging and exploratory surgery are needed.

The diagnostic approach to hepatic cysts begins with a thorough history and physical examination, including abdominal palpation. If hepatomegaly or abdominal distension is noted, baseline blood work (CBC, serum biochemistry, urinalysis) is performed to assess liver function and rule out other causes. Abdominal ultrasonography is the next step, as it is highly sensitive for detecting cystic lesions and characterizing their number, size, wall thickness, and content. If cysts are simple and asymptomatic, no further diagnostics may be needed. However, if cysts are complex (thick-walled, septated, or containing echogenic material), or if clinical signs are present, fine-needle aspiration (FNA) of the cyst fluid is indicated for cytology, culture, and fluid analysis. If neoplasia is suspected, ultrasound-guided biopsy (Tru-Cut or surgical) is recommended. Advanced imaging such as CT or MRI may be useful for surgical planning, especially for large or multiple cysts. In cases of suspected polycystic disease, renal ultrasonography should be performed to evaluate for concurrent renal cysts. Genetic testing for PKD1 mutations is available for Persian cats. If parasitic disease is suspected, serology (ELISA) for Echinococcus and histopathology of the cyst wall are confirmatory. The diagnostic algorithm should be stepwise, starting with non-invasive imaging and progressing to invasive sampling only when clinically indicated.

Laboratory findings in hepatic cysts are often unremarkable unless there is significant hepatic dysfunction or complications. Complete blood count (CBC) may show leukocytosis with a left shift if there is secondary infection or inflammation. Serum biochemistry may reveal elevated liver enzymes (ALT, AST, ALP, GGT) if there is biliary obstruction or hepatocellular damage. Bilirubin may be elevated in cases of extrahepatic biliary obstruction. Hypoalbuminemia may occur with chronic liver disease. Coagulation parameters (PT, aPTT) may be prolonged if liver function is severely impaired. Urinalysis may show bilirubinuria, and if concurrent polycystic kidney disease is present, there may be isosthenuria, proteinuria, and elevated urine protein-to-creatinine ratio. Blood gas analysis may reveal metabolic acidosis in cases of sepsis or shock. Specific biomarkers such as serum bile acids may be elevated if there is portosystemic shunting. In cases of parasitic cysts, serology for Echinococcus antibodies may be positive. Cytology of cyst fluid typically shows acellular or paucicellular fluid with low protein content, consistent with a transudate. If infected, fluid analysis may show septic suppurative inflammation with bacteria.

Imaging plays a crucial role in the diagnosis of hepatic cysts. Abdominal radiography may show hepatomegaly or a soft tissue mass effect, but is not specific. Ultrasonography is the modality of choice: simple cysts appear as anechoic, well-defined, round or oval structures with distal acoustic enhancement and thin, smooth walls. Multiple cysts may be seen in polycystic disease. Complex cysts may have thick walls, septations, or echogenic contents (e.g., debris, hemorrhage, or infection). Color Doppler can assess vascularity of the cyst wall, which is typically absent in simple cysts. Computed tomography (CT) provides excellent anatomical detail and is useful for surgical planning, especially for large cysts or when multiple cysts are present. CT may show well-circumscribed, hypoattenuating lesions with no contrast enhancement. Magnetic resonance imaging (MRI) is rarely needed but can characterize cyst content and rule out neoplasia. Endoscopic retrograde cholangiopancreatography (ERCP) is not commonly performed in veterinary medicine but could be used to evaluate biliary communication. Fluoroscopy may be used during contrast studies to assess biliary drainage. Echocardiography is not directly relevant, but if portal hypertension is suspected, Doppler ultrasound of the portal vein can measure flow velocity and direction.

Cytological evaluation of cyst fluid is essential to differentiate simple cysts from neoplastic or infectious processes. Fine-needle aspiration (FNA) of a simple cyst yields clear, colorless to straw-colored fluid with low cellularity, typically containing few epithelial cells or macrophages. Fluid analysis shows a transudate (low protein, low nucleated cell count). If the cyst is infected, the fluid may be turbid, with high protein and cellularity, and bacteria may be seen on cytology. Histopathology of the cyst wall is the gold standard for definitive diagnosis. Simple cysts are lined by a single layer of cuboidal or columnar epithelium, with a thin fibrous wall. Polycystic disease shows multiple cysts lined by biliary epithelium, often with associated fibrosis. Cystadenomas have papillary projections and may show cellular atypia, while cystadenocarcinomas exhibit invasion and anaplasia. Special stains, such as periodic acid-Schiff (PAS), may highlight mucin in biliary epithelium. Immunohistochemistry for cytokeratin markers can confirm biliary origin. In parasitic cysts, the wall may contain characteristic laminated layers and protoscolices.

Treatment of hepatic cysts depends on the clinical signs and underlying cause. Asymptomatic cysts do not require treatment, but regular monitoring is recommended. For symptomatic cysts, options include: 1) Medical management: If infection is present, appropriate antibiotics (based on culture and sensitivity) are administered. For polycystic disease, there is no specific medical therapy, but management of concurrent renal disease is essential. 2) Surgical intervention: For large or symptomatic cysts, surgical options include cyst fenestration (deroofing), partial hepatectomy, or marsupialization. Laparoscopic fenestration is minimally invasive and may be preferred. In cases of polycystic disease, if a single dominant cyst is causing signs, fenestration may provide relief. 3) Percutaneous drainage: Ultrasound-guided aspiration of cyst fluid can be performed for diagnostic or therapeutic purposes, but recurrence is common. Sclerotherapy with ethanol or doxycycline may be used to reduce recurrence, but is not widely reported in veterinary medicine. 4) Management of complications: If cyst rupture occurs, emergency stabilization with fluid therapy and surgery may be needed. If portal hypertension develops, medical management with diuretics (e.g., spironolactone) and a low-sodium diet may be indicated. 5) Supportive care: Hepatoprotectants (e.g., S-adenosylmethionine, silymarin) may be used, though evidence is limited. Nutritional support with a high-quality, easily digestible diet is important. In cases of parasitic cysts, surgical excision is the treatment of choice, and antiparasitic drugs (e.g., albendazole) may be used adjunctively.

The prognosis for hepatic cysts is generally good if they are asymptomatic and not associated with significant hepatic dysfunction. Simple cysts that are surgically removed have an excellent prognosis. Polycystic liver disease carries a guarded prognosis, as it is progressive and often associated with renal failure, which determines the long-term outcome. In Persian cats with PKD, the median survival time is around 3-5 years after diagnosis of renal disease. Complications such as infection, rupture, or malignancy worsen the prognosis. Negative prognostic indicators include the presence of clinical signs, large cyst size, multiple cysts, concurrent renal disease, and evidence of neoplasia. With appropriate management, many animals can live comfortably for years.

Follow-up for hepatic cysts depends on the severity and treatment. Asymptomatic cysts should be re-evaluated with abdominal ultrasound every 6-12 months to monitor for changes in size or number. After surgical treatment, re-check ultrasound at 1-3 months post-operatively to assess for recurrence. If medical management is instituted for concurrent conditions (e.g., renal disease), regular monitoring of renal parameters (creatinine, SDMA, UPC) is recommended. For animals with polycystic disease, blood pressure monitoring and urinalysis should be performed regularly. If antibiotics are used for infection, a repeat culture may be indicated after treatment. Long-term management includes periodic liver enzyme evaluation and bile acid testing if hepatic function is compromised. Owners should be educated on signs of complications, such as abdominal pain, vomiting, or jaundice, and advised to seek immediate veterinary care if these occur.

Pearls: 1) Hepatic cysts are often incidental findings; avoid over-treatment if asymptomatic. 2) Ultrasonography is the most sensitive diagnostic tool; simple cysts have characteristic anechoic appearance with distal enhancement. 3) In Persian cats, always evaluate kidneys for concurrent PKD. 4) If a cyst is complex (thick-walled, septated), consider neoplasia or infection and perform FNA. 5) Surgical fenestration is effective for large symptomatic cysts. Pitfalls: 1) Mistaking a biliary mucocele for a cyst – mucoceles have a stellate pattern and require different management (cholecystectomy). 2) Aspirating a cyst without ultrasound guidance may cause hemorrhage or rupture. 3) Assuming all cysts are benign – always consider cystadenocarcinoma. 4) Ignoring concurrent renal disease in polycystic cases, which is the main determinant of prognosis. 5) Using corticosteroids without ruling out infection, which can worsen sepsis.

There is no specific drug therapy for hepatic cysts per se. However, for secondary infections, antibiotics should be chosen based on culture and sensitivity. Common empirical choices include amoxicillin-clavulanate (12.5-25 mg/kg PO q8-12h) or enrofloxacin (5-10 mg/kg PO/IV q24h). For parasitic cysts (Echinococcus), albendazole (10-15 mg/kg PO q12h for 28 days) is recommended, but surgical excision is primary. For portal hypertension, spironolactone (1-2 mg/kg PO q12h) and furosemide (1-2 mg/kg PO/IV q8-12h) may be used, with careful monitoring of electrolytes. Hepatoprotectants such as S-adenosylmethionine (SAMe) (20 mg/kg PO q24h) and silymarin (10-20 mg/kg PO q8-12h) may be used as adjunctive therapy. Ursodeoxycholic acid (10-15 mg/kg PO q24h) can be used if cholestasis is present. For pain management, opioids such as buprenorphine (0.01-0.02 mg/kg IV/IM q8-12h) or NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) may be used post-operatively, but caution with hepatic disease. All dosages should be adjusted for renal/hepatic impairment, and drug interactions should be considered.

Evidence-based literature on hepatic cysts in veterinary medicine is limited. Most information comes from case reports and small case series. A study by Bosje et al. (1998) described polycystic liver and kidney disease in Persian cats, highlighting the autosomal dominant inheritance and the need for screening. Another study by Biller et al. (1990) established the ultrasonographic criteria for PKD in Persian cats. In dogs, polycystic liver disease has been reported in Cairn Terriers, with a genetic basis. Surgical management of hepatic cysts has been described in case reports, with fenestration being the most common technique. A retrospective study by Aprea et al. (2012) evaluated laparoscopic fenestration in dogs and cats, showing good outcomes with minimal complications. There are no large clinical trials evaluating medical therapies for hepatic cysts. Consensus guidelines from ACVIM and ECVIM on liver disease do not specifically address hepatic cysts, but they recommend a stepwise diagnostic approach and emphasize the importance of histopathology for complex cysts. Further research is needed to establish evidence-based treatment protocols.